DutaFabs are engineered therapeutic Fab fragments that can bind two targets simultaneously

Bispecific antibodies can bind to two distinct targets though the fusion of two different Fv regions. In this study, the authors develop DutaFabs that present two separated and independent antigen binding sites within the same Fv region, giving rise to bispecific Fab fragments.

Saved in:
Bibliographic Details
Main Authors: Roland Beckmann, Kristian Jensen, Sebastian Fenn, Janina Speck, Katrin Krause, Anastasia Meier, Melanie Röth, Sascha Fauser, Raymond Kimbung, Derek T. Logan, Martin Steegmaier, Hubert Kettenberger
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Q
Online Access:https://doaj.org/article/70c0f8f5eaae4c48be3ad457ee0a7a4b
Tags: Add Tag
No Tags, Be the first to tag this record!